🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jaya Kala

Texas Medical Center

ORCID: 0000-0003-2056-1721

Also affiliated with The University of Texas Health Science Center, The University of Texas Health Science Center at Houston

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Risk Factors for Severe Hypertension and Proteinuria After Treatment With Vascular Endothelial Growth Factor Signaling Pathway Inhibitors Among Patients With Cancer”.

Risk Factors for Severe Hypertension and Proteinuria After Treatment With Vascular Endothelial Growth Factor Signaling Pathway Inhibitors Among Patients With Cancer

Kidney International Reports(2024)10.1016/j.ekir.2024.03.005

N/A

0.396DataRank · unranked

13 citations

Rajesh Anumolu, Shveta S. Motwani, Kevin L. Chen, Nurit Katz‐Agranov, Olivia Green‐Lingren +7 more

Case Report: Successful treatment of late-onset immune checkpoint inhibitor-associated membranous nephropathy in a patient with advanced renal cell carcinoma

Frontiers in Immunology(2022)10.3389/fimmu.2022.898811

N/A

0DataRank · unranked

15 citations

Vikas D. Reddy, Jaya Kala, Amanda Tchakarov, William F. Glass, Pavlos Msaouel +2 more

Diagnosis and management of immune checkpoint inhibitor–associated nephrotoxicity: a position statement from the American Society of Onco-nephrology

Kidney International(2024)10.1016/j.kint.2024.09.017

N/A

0DataRank · unranked

45 citations

Ala Abudayyeh, Shruti Gupta, Prakash Gudsoorkar, Nattawat Klomjit, Shveta S. Motwani +11 more